Related by context. All words. (Click for frequent words.) 78 histopathologic 77 histopathological 77 morphologic 75 histological 73 Histologic 72 clinicopathologic 71 lymph node metastasis 71 pathologic 71 immunohistochemical 71 mucinous 71 Histological 70 clinicopathological 70 histologic findings 70 histopathologic examination 70 lymph node metastases 70 histologically 70 lymphovascular invasion 69 cytologic 69 pathologic diagnosis 69 immunostaining 69 lymph node involvement 69 ultrasonographic 69 HRCT 69 urothelial carcinoma 69 sonographic findings 69 distant metastasis 69 biochemical recurrence 69 microsatellite instability 68 axillary lymph node 68 plain radiographs 68 nodal metastases 68 parenchymal 68 histologic examination 68 scintigraphic 68 clinicopathological features 68 immunohistochemical analysis 68 sonographic 68 histological subtype 68 neoplasm 67 neoplastic 67 intraobserver 67 luminal 67 pT2 67 Lymph node 67 neuropathological 67 prognostic significance 67 Histologically 67 pathologic examination 67 prostate cancer CaP 67 mediastinal 67 wedge resection 67 chest radiograph 67 lymphadenectomy 67 sarcomatoid 67 echogenicity 67 breast carcinoma 67 T1a 67 immunoreactivity 66 immunohistochemical staining 66 cellularity 66 radiographic findings 66 thyroglobulin 66 Preoperative 66 neoplasms 66 peritumoral 66 histologic subtype 66 Histopathologic 66 hamartomas 66 TOP2A gene 66 endometrioid 66 liver metastasis 66 histology 66 interobserver 66 splenic 66 pT3 66 preoperative diagnosis 66 tumoral 66 nodular 66 gastric carcinoma 66 esophageal carcinoma 66 liver histology 66 carcinoids 66 intraoperative complications 65 Figure 2C 65 echocardiographic 65 hyperintensity 65 intestinal metaplasia 65 hypervascular 65 urothelial 65 neoadjuvant therapy 65 SLNB 65 univariate analysis 65 hepatocellular carcinomas 65 pCR 65 pelvic lymphadenectomy 65 axillary lymph nodes 65 synovial 65 FDG-PET/CT 65 PCa 65 lymphocytic 65 histopathologic findings 65 histopathologic diagnosis 65 metaplasia 65 nodal metastasis 65 radical prostatectomy RP 65 osteochondroma 65 mesenteric 65 HER2 expression 65 squamous 65 adenoma 65 glomerular 65 hyperplastic 64 ultrastructural 64 cytokeratin 64 posttreatment 64 cytological 64 multivariate Cox 64 proximal colon 64 tumor histology 64 nonmetastatic 64 gadolinium enhanced 64 EUS FNA 64 hypoechoic 64 radical nephrectomy 64 hilar 64 hydronephrosis 64 pneumonectomy 64 epididymal 64 etiologic 64 pituitary adenomas 64 precursor lesions 64 breast carcinomas 64 histopathological examination 64 intact parathyroid hormone 64 Kaplan Meier analysis 64 advanced adenoma 64 preoperative PSA 64 histological examination 64 surgically resected 64 prostate carcinoma 64 transabdominal 64 renal pelvis 64 haematologic 64 pericardial effusion 64 papillary renal cell carcinoma 64 mRNA expression 64 synovial tissue 64 distant metastases 64 Gram stain 64 transesophageal echocardiography 64 FDG uptake 64 nodal dissection 64 KRAS mutation 64 resected 64 clinico pathological 64 supratentorial 64 haematological 64 urine cytology 64 locoregional recurrence 64 prognostic factor 64 NMIBC 64 malignant lesions 64 thyroid carcinoma 63 calculi 63 renal tumors 63 karyotype 63 Hurthle cell 63 gastric adenocarcinoma 63 renal allograft 63 NIHSS 63 Immunohistochemical staining 63 leiomyoma 63 leiomyomas 63 multivariate analyzes 63 hypointense 63 pseudoaneurysm 63 response pCR 63 neoplasias 63 pleomorphic 63 prognostic factors 63 extracranial 63 HSCT 63 underwent resection 63 oncologic outcomes 63 interobserver reliability 63 perioperative complications 63 carcinoid tumor 63 extranodal 63 coronary stenosis 63 CD# expression [002] 63 F FDG PET 63 papillary 63 pheochromocytoma 63 sonographic appearance 63 chest radiographs 63 transvaginal sonography 63 AST ALT 63 fatty infiltration 63 peritoneal 63 posttransplant 63 adrenalectomy 63 adnexal mass 63 Immunohistochemical analysis 63 pulmonary metastases 63 prognostic indicators 63 Doppler sonography 63 T1 weighted images 63 cTnI 63 intraoperative 63 left ventricular LV 63 axillary node 63 lobular 63 metastatic lesion 63 Immunohistochemical 63 SUVmax 63 adenomatous polyps 63 HNSCC 63 metastatic lesions 63 villous 63 biopsy Gleason 63 mesotheliomas 63 bone scintigraphy 63 prognostic variables 63 RECIST Response Evaluation Criteria 63 Multivariate analysis 63 postoperative complication 63 HGPIN 62 sonographic examination 62 gastroduodenal 62 TMPRSS2 ERG fusion 62 Subgroup analyzes 62 TIMP 1 62 micrometastasis 62 retroperitoneal 62 lung metastasis 62 pancreatic adenocarcinoma 62 advanced neoplasia 62 ductal 62 resectable 62 TIMP 62 multivariable analysis 62 Secondary endpoints included 62 endocervical 62 nephron sparing surgery 62 T2 weighted images 62 malignant fibrous histiocytoma 62 epithelial tumors 62 nephrectomy 62 hypoplasia 62 paragangliomas 62 Radiographs 62 pretransplant 62 biopsy specimens 62 steatosis 62 submucosal 62 rs# [002] 62 biochemical relapse 62 Immunohistochemistry 62 CIN3 62 malignant nodules 62 COL#A# 62 allelic 62 arthrography 62 lymphoid cells 62 univariate 62 carotid stenosis 62 radiographically 62 FDG PET 62 prostatic 62 colorectal adenoma 62 invasive carcinomas 62 polypoid 62 antibody titer 62 histologically proven 62 para aortic 62 Postoperative 62 malignant neoplasm 62 P cadherin 62 hyperplastic polyps 62 computed tomographic scan 62 prospectively defined 62 axillary dissection 62 histologic subtypes 62 tumor resection 62 epithelioid 62 acute aortic dissection 62 radical cystectomy 62 transthoracic 62 PSADT 62 transgene expression 62 LVNC 62 adenomatous 62 endothelial activation 62 erythrocyte sedimentation rate 62 thymoma 62 P = .# 62 troponin T 62 perineural invasion 62 ASCUS 62 sonographically guided 62 preoperative chemotherapy 62 renal cell carcinomas 62 MALT lymphoma 62 CIN2 + 62 cytoreductive surgery 62 neuropathologic 62 undetectable HBV DNA 62 granulomatous 62 radiographic 62 varices 62 normal karyotype 61 aortic regurgitation 61 localized renal 61 extramedullary 61 Sonographic 61 histologies 61 Figure 1A 61 prospective multicenter study 61 TNM staging 61 Subgroup analysis 61 tumor recurrence 61 serrated polyps 61 resected pancreatic cancer 61 cTnT 61 K ras mutations 61 perfusion defect 61 gastrectomy 61 bivariate analysis 61 locoregional 61 GISTs 61 carcinoembryonic antigen 61 osteoid 61 sonographically 61 oropharyngeal 61 schwannomas 61 hypoperfusion 61 lymph node dissection 61 T1c 61 microRNA expression 61 ERCC1 61 neoplasia 61 lymphocytosis 61 ^ sup #m 61 pleural fluid 61 ROC curves 61 IL#B 61 resection 61 recanalization 61 extracapsular extension 61 osteochondromas 61 #F FDG PET 61 myxoid 61 cytogenic 61 hepatic metastases 61 ventricular myocardium 61 ischemic lesions 61 metachronous 61 acetabular fractures 61 tumorigenicity 61 tumor necrosis 61 bronchoalveolar lavage BAL 61 percutaneous biopsy 61 semiquantitative 61 cardiac troponin 61 explants 61 transurethral resection 61 intima media thickness 61 WOMAC pain 61 Secondary endpoints 61 sonographic evaluation 61 grade cervical intraepithelial 61 intrahepatic 61 SSc 61 infarcts 61 lateral radiograph 61 multivariable analyzes 61 graft dysfunction 61 monoclonal gammopathy 61 microvessel 61 hepatectomy 61 papillary RCC 61 carcinoma 61 sulcal 61 colorectal adenocarcinoma 61 ovarian carcinoma 61 endoscopic ultrasonography 61 lymphopenia 61 postintervention 61 histologic diagnosis 61 resections 61 periventricular 61 adenocarcinomas 61 #q#.# [001] 61 bronchoalveolar lavage 61 prognostic biomarker 61 carotid IMT 61 node metastases 61 Kaplan Meier curves 61 femoral neck fracture 61 hyperechoic 61 advanced adenomas 61 chromosomal mutations 61 malignant lymphoma 61 Kaplan Meier 61 duplex ultrasonography 61 prostatic adenocarcinoma 61 thyroid nodules 61 seminal vesicle invasion 61 intratumoral 61 Index CDAI 61 angiographically 61 peripheral blood mononuclear 61 Bonferroni correction 61 estrogen receptor ER 61 familial clustering 61 stage IIIA 61 LV ejection fraction 61 Ki# 61 alkaline phosphatase ALP 61 abnormal cytology 61 epithelial cell 61 immunohistochemistry IHC 61 hematuria 61 arteriography 61 Fig. 1D 61 SCr 61 rebleeding 61 melanocytic 61 lymphadenopathy 61 TRUS 61 laterality 61 invasive carcinoma 61 biopsy specimen 60 HER2 overexpression 60 HBeAg 60 inhibin 60 choroidal 60 axillary node dissection 60 radiotherapy RT 60 thymectomy 60 endometrial 60 HBsAg 60 endometrial carcinoma 60 orthotopic 60 malignant transformation 60 pancreatic carcinoma 60 vesicoureteral reflux 60 radiochemotherapy 60 myometrium 60 RVOT 60 definite stent thrombosis 60 pulmonary nodules 60 rCBF 60 liver transaminases 60 KRAS mutations 60 colorectal carcinoma 60 lobular carcinoma 60 motor neuron degeneration 60 inducible nitric oxide synthase 60 micrometastases 60 CD# expression [001] 60 cervical lymph nodes 60 histological subtypes 60 lesional 60 electrophysiologic 60 excisional biopsy 60 renal cysts 60 lactate dehydrogenase 60 antitumour activity 60 DAS# CRP 60 Secondary endpoints include 60 Primary endpoints 60 Univariate analysis 60 demyelinating 60 mediastinum 60 glomerular filtration 60 obstructive coronary 60 tracer uptake 60 Brief Psychiatric 60 pathologic fractures 60 talar 60 -#.# ± [002] 60 stromal 60 duodenal 60 neoplastic lesions 60 atherosclerotic lesions 60 epithelial 60 infiltrative 60 prostate cancer PCa 60 chest radiography 60 esophageal squamous cell carcinoma 60 estimated glomerular filtration 60 bladder carcinoma 60 MLH1 60 ascending aortic 60 adjuvant radiotherapy 60 serum PSA 60 EGFR expression 60 pulmonary artery banding 60 preoperatively 60 hepatic lesions 60 ureteral 60 neuritic 60 metastatic lymph nodes 60 histological diagnosis 60 Response Evaluation Criteria 60 serum ferritin 60 basal cell carcinoma BCC 60 preoperative 60 ovarian malignancy 60 postoperative morbidity 60 Multivariate logistic regression 60 virologic responses 60 squamous histology 60 promoter methylation 60 specific antigen PSA 60 morphologic characteristics 60 hepatic arterial 60 independent prognostic marker 60 TMPRSS2 ERG 60 cystectomy 60 cervical carcinoma 60 axillary nodes 60 VATS lobectomy 60 morphological 60 carcinomas 60 RRM1 60 Histological examination 60 ventilation perfusion 60 System IPSS 60 curative resection 60 B7 H3 60 histopathology 60 neoadjuvant chemotherapy 60 TOP2A 60 endobronchial 60 myeloperoxidase 60 Papillary 60 covariate 60 anteroposterior 60 CR nPR 60 chemosensitivity 60 hormone receptor status 60 ALND 60 endometrial adenocarcinoma 60 extrahepatic 60 MGUS 60 vascularity 60 germline mutations 60 postoperative chemotherapy 60 seminal vesicle 60 MACCE 60 malignant polyps 60 echogenic 60 adrenocortical 60 cytogenetic 60 Prognostic factors 60 F FDG uptake 60 Radiographic 60 gene rearrangements 60 autonomic dysfunction 60 appendiceal 60 lactate dehydrogenase LDH 60 perioperative morbidity 60 PCWP 60 cancer mCRC 60 serum ALT 60 androgen deprivation 60 cholelithiasis 60 myocardial ischemia 60 logistic regression analyzes 60 seropositivity 60 perianal 60 CCyR 60 trabecular bone 60 neoadjuvant 60 KRAS wild 60 H#K#me# 60 ductal adenocarcinoma 60 MDCT angiography 60 urodynamic 60 situ LCIS 60 Western blotting 60 alkaline phosphatase 60 Sjögren syndrome 60 chondral 60 variant allele 60 gene amplification 60 intracerebral 60 varicoceles 60 hamartoma 60 malignant prostate 60 symptomatic VTE 60 serologic 60 airway hyperresponsiveness 60 cytoreduction 60 papillary carcinoma 60 Kaplan Meier method 60 metastases 60 #.#ng/ml 60 autoregulation 59 grade squamous intraepithelial 59 penetrance 59 colonoscopic 59 hematoxylin 59 antiphospholipid antibodies 59 conjunctival 59 prespecified secondary 59 neointimal 59 noncalcified 59 miRNA expression 59 Plain radiographs 59 Computed tomography 59 pulmonary resection 59 somatic mutation 59 BRCA2 mutation carriers 59 #p# [003] 59 leukocytosis 59 thyroid carcinomas 59 Ultrasonographic 59 tonsillar 59 interobserver agreement 59 adnexal masses 59 opacification 59 resected tumors 59 genotypic resistance 59 paraganglioma 59 serum antibody 59 bronchoalveolar 59 articular 59 hepatic fibrosis 59 immunocompetent 59 dyssynchrony 59 malignant ovarian 59 aminotransferase 59 proteoglycan 59 operable breast cancer 59 nonmalignant 59 osteoclastic 59 lateral radiographs 59 anti JCV antibodies 59 rs# [004] 59 segmentectomy 59 spontaneous regression 59 liver metastases 59 immunohistochemistry 59 EBUS FNA 59 TP# mutations 59 osteoid osteoma 59 hormone receptor negative 59 chemoradiotherapy 59 molecular subtypes 59 myeloablative 59 cytologically 59 sonographic diagnosis 59 nephrogenic 59 ERBB2 59 valvular 59 SNP rs# [002] 59 nondiagnostic 59 Adenomas 59 biochemical abnormalities 59 UGT#A# * 59 clinically insignificant 59 cosmesis 59 ABCB1 59 completely resected 59 multiple logistic regression 59 aneurysmal 59 transient elastography 59 eosin 59 atypical squamous cells 59 Intraoperative 59 NP CRNs 59 vascularisation 59 remission CR 59 prognostic marker 59 breast cancer subtypes 59 parathyroidectomy 59 occlusive disease 59 Echocardiographic 59 cytologically confirmed 59 cerebrospinal fluid CSF 59 CC genotype 59 nonalcoholic steatohepatitis NASH 59 atherosclerotic lesion 59 fibrosis 59 eccrine 59 lesions 59 virologic response 59 multiplanar 59 multivariate logistic regression 59 urothelial cancer 59 colorectal neoplasms 59 interrater reliability 59 CR CRu 59 cholangiocarcinoma 59 follicular thyroid cancer 59 coronary artery stenosis 59 hyperintense lesions 59 Histopathologic examination 59 ependymomas 59 hyperplasia 59 esophagectomy 59 contralateral breast 59 Cytogenetic 59 perioperative mortality 59 PTPN# 59 radicular 59 Univariate 59 HepG2 cells 59 Kaplan Meier survival 59 multicentric 59 apolipoproteins 59 hyperintensities 59 sinonasal 59 ductal carcinomas 59 pathophysiologic 59 microvessel density 59 noncardiac 59 DNA methylation patterns 59 cystoscopic 59 evaluable 59 distal femur 59 desmoplastic 59 pelvic ultrasound 59 hepatocellular carcinoma 59 POAG 59 Histopathological 59 lesion 59 Endothelial dysfunction 59 CSF biomarkers 59 progression TTP 59 elevated ALT 59 demyelination 59 K ras 59 oncological outcomes 59 sentinel lymph node biopsy 59 microglial 59 subclinical 59 MR spectroscopy 59 NGAL 59 familial aggregation 59 unfavorable cytogenetics 59 obscure gastrointestinal bleeding 59 carcinoid tumors 59 debulking surgery 59 hepatic 59 epithelia 59 PSA kinetics 59 thyroid peroxidase 59 Crohn Disease Activity 59 Trichophyton rubrum 59 qRT PCR 59 TRAIL R1 59 transitional cell carcinoma 59 immunofluorescent 59 Leydig cell 59 mycosis fungoides 59 dysplastic 59 bladder tumors 59 sensitivity specificity 59 Kaplan Meier curve 59 intracranial hemorrhage ICH 59 adrenal masses 59 graft occlusion 59 poorer prognosis 59 nonfatal MI 59 perivascular 59 hyperacute 59 vascular lesion 59 teratoma 59 digital subtraction angiography 59 Insulin sensitivity 59 troponins 59 chemoresistant 59 astrocytic 59 anatomic structures 59 aortic coarctation 59 NNRTI resistance 59 FDG PET imaging 59 pulmonary infiltrates 59 karyotypes 59 alanine aminotransferase 59 postoperative radiotherapy 59 elevated LDH 59 Cystatin C 59 hematopoietic cancers 59 CDH1 59 #p# [001] 59 histologically confirmed 59 axillary 59 invasive ductal 59 primary hyperparathyroidism 59 premalignant 59 CTEPH 59 LV dysfunction 59 carotid plaque 59 computed tomographic scans 59 posaconazole 59 tunica vaginalis 58 mammographic 58 abdominal computed tomography 58 paraneoplastic 58 amyloid deposition 58 Radical prostatectomy 58 papillary thyroid carcinoma 58 osseous 58 serum prostate 58 fractional anisotropy 58 atypical hyperplasia 58 sCJD 58 microdeletion 58 obstructive coronary artery 58 FGFR2 gene 58 carcinoid 58 BCR ABL mutations 58 premalignant lesions 58 NIHSS score 58 hepato 58 CORE OM 58 exploratory endpoints 58 anatomic 58 fibroma 58 antral 58 cytotoxicity 58 lung metastases 58 contrast echocardiography 58 lumbar disc herniation 58 primary aldosteronism 58 endometrial thickness 58 immunocytochemistry 58 ANOVA 58 Kruskal Wallis test 58 HRQOL 58 Histological analysis 58 myocyte 58 induced sputum 58 prognostically 58 esophagogastric junction 58 sentinel node 58 viable myocardium 58 distal 58 allele frequencies 58 lymphoid 58 unfavorable prognostic 58 EGFR mutations 58 florbetaben 58 phenotype 58 IgA deficiency 58 cholestasis 58 unknown etiology 58 jugular venous 58 endometrial biopsy 58 small lymphocytic lymphoma 58 prognostic indicator 58 artery stenosis 58 Figure 1C 58 trophoblast cells 58 tumor subtype 58 septal 58 neutropaenia 58 kidney allograft 58 mediastinal lymph nodes 58 serological 58 apo B 58 sternotomy 58 MR imaging 58 lumbar disk herniation 58 clefting 58 myocardial viability 58 serum HBV DNA 58 Solid Tumors RECIST 58 ascites 58 transaminases 58 PSA nadir 58 #q#.# [002] 58 gene polymorphisms 58 adjuvant therapies 58 prespecified 58 squamous carcinoma 58 somatic mutations 58 stenoses 58 carcinomatosis 58 autophagic 58 methacholine challenge 58 renal cortical 58 telomere lengths 58 microdeletions 58 pancreatic fistula 58 intraperitoneal 58 parenchyma 58 posttraumatic 58 inhibin B 58 haematopoietic 58 intracranial 58 preoperative staging 58 biventricular repair 58 mononuclear 58 dysplasia 58 Disease Activity 58 lung adenocarcinomas 58 pelvic lymph nodes 58 serum aminotransferase levels 58 ileal 58 situs inversus 58 nonischemic 58 creatine kinase MB 58 aplasia 58 APOE e4 58 periosteal 58 TNFalpha 58 unresectable tumors 58 necrotic core 58 affective psychosis 58 MSH2 58 diffusion tensor 58 neoplastic cells 58 aggrecan 58 left ventricular systolic 58 morphometry 58 tumor lysis syndrome 58 Pathologic 58 SLN biopsy 58 osteogenic 58 infarct 58 nodular partial response 58 tumor regressions 58 ipsilateral stroke 58 dimensional echocardiography 58 p = #.# [003] 58 proximal tubule 58 immunologic 58 colorectal polyp 58 chromosomal rearrangement 58 Secondary efficacy endpoints 58 thymic carcinoma 58 central corneal thickness 58 leukocyte count 58 squamous intraepithelial lesions 58 univariate analyzes 58 intraventricular 58 polyposis 58 periprosthetic fracture 58 microvascular 58 neovascular 58 contralateral 58 serum creatinine levels 58 LVEF 58 hENT1 58 hepatic cirrhosis 58 ipsilateral 58 reflux esophagitis 58 cardiac dysfunction 58 subtrochanteric 58 visceral metastases 58 C telopeptide 58 ipsilateral breast 58 cytogenetic abnormalities 58 alanine aminotransferase ALT 58 extraocular 58 Multiple logistic regression 58 vimentin 58 colorectal adenomas 58 % CI #.#-#.# [007] 58 HIV HCV coinfected 58 invasive lobular 58 systolic function 58 lacunar 58 fine needle aspiration 58 pulmonary angiography 58 penetrating keratoplasty 58 malperfusion 58 clinically meaningful differences 58 thromboembolic 58 SELENA SLEDAI 58 T2 weighted MRI 58 cytogenetic response 58 PCNSL 58 liver resection 58 epithelial ovarian cancer 58 supraclavicular 58 eosinophil count 58 p# mutations 58 ecchymosis 58 nephrotoxicity 58 pleural effusion 58 external beam radiotherapy 58 adnexal 58 HDRS 58 ductal lobular 58 methylation patterns 58 hallux valgus 58 immunofluorescence 58 trabecular 58 vasogenic edema 58 Preoperatively 58 spirometric 58 progesterone receptor PR